可注射PrEP是否优于口服治疗以保护艾滋病毒?
David Kriegel1, Anthony Daniels1, Dean A Seehusen1
1Medical College of Georgia, Augusta.
The Journal of family practice
|August 7, 2023
概括
长效注射式卡博特格拉维尔在预防艾滋病毒感染方面表现出明显的结果,为每日口服预暴露预防提供了替代方案.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 临床试验 临床试验
背景情况:
- 艾滋病毒暴露前预防 (PrEP) 对于预防艾滋病毒传播至关重要.
- 每日口服PrEP,如tenofovir-emtricitabine,是当前的标准,但遵守可能具有挑战性.
研究的目的:
- 为了比较长效可注射卡博特格拉维尔的疗效和安全性,与每日口服天诺福维尔-emtricitabine用于HIV暴露前预防.
主要方法:
- 进行了一项随机对照试验 (RCT).
- 参与者接受了长期作用的注射性卡博特格拉维尔或每天口服的特诺福维尔-埃姆特里西塔宾.
- 在研究期间评估了有效性和安全性结果.
主要成果:
- 长效注射卡博特格拉维尔在预防艾滋病毒感染方面表现出明显的有效性.
- 可注射配方为每日口服方案提供了重要的替代方案.
- 评估了这两种干预措施的安全性.
结论:
- 长效注射卡博特格拉维尔是HIV暴露前预防的有效选择.
- 这种可注射PrEP可以改善坚持和减少艾滋病毒传播率.
相关概念视频
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Insulin Formulations: Types and Delivery
226
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
226
Sexually Transmitted Infections
349
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
349
Routes of Drug Administration: Parenteral
2.0K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.0K
Drug Delivery: Parenteral Route
618
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
618
Factors Influencing Drug Absorption: Presystemic Elimination
263
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
263


